Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: nab-paclitaxel|DRUG: Bevacizumab|DRUG: Trastuzumab
Sponsor: SCRI Development Innovations, LLC
Collaborators: Celgene Corporation|Genentech, Inc.